01:36 , Oct 18, 2008 |  BC Extra  |  Clinical News

Boehringer unveils diabetes pipeline

Boehringer Ingelheim (Ingelheim, Germany) announced its entrance into the Type II diabetes drug development space as it unveiled three products in late-stage testing. The compounds include: Ondero ( BI 1356 ), a dipeptidyl peptidase-4 (DPP-4)...